Golden Biotechnology Stock Revenue
| 4132 Stock | TWD 16.50 0.15 0.92% |
Golden Biotechnology fundamentals help investors to digest information that contributes to Golden Biotechnology's financial success or failures. It also enables traders to predict the movement of Golden Stock. The fundamental analysis module provides a way to measure Golden Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Golden Biotechnology stock.
Golden |
Golden Biotechnology Company Revenue Analysis
Golden Biotechnology's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Golden Biotechnology Revenue | 78.35 M |
Most of Golden Biotechnology's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Golden Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Golden Biotechnology reported 78.35 M of revenue. This is 98.97% lower than that of the Healthcare sector and 96.68% lower than that of the Drug Manufacturers - Specialty & Generic industry. The revenue for all Taiwan stocks is 99.17% higher than that of the company.
Golden Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Golden Biotechnology's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Golden Biotechnology could also be used in its relative valuation, which is a method of valuing Golden Biotechnology by comparing valuation metrics of similar companies.Golden Biotechnology is rated fifth in revenue category among its peers.
Golden Fundamentals
| Return On Equity | -36.95 | |||
| Return On Asset | -17.85 | |||
| Operating Margin | (414.69) % | |||
| Current Valuation | 5.17 B | |||
| Shares Outstanding | 115.76 M | |||
| Price To Book | 6.75 X | |||
| Price To Sales | 65.71 X | |||
| Revenue | 78.35 M | |||
| Gross Profit | 51.31 M | |||
| EBITDA | (279.28 M) | |||
| Net Income | (336.49 M) | |||
| Cash And Equivalents | 152.56 M | |||
| Cash Per Share | 1.33 X | |||
| Total Debt | 227.3 M | |||
| Debt To Equity | 30.10 % | |||
| Current Ratio | 2.78 X | |||
| Book Value Per Share | 6.59 X | |||
| Cash Flow From Operations | (306.43 M) | |||
| Earnings Per Share | (2.97) X | |||
| Number Of Employees | 135 | |||
| Beta | 0.72 | |||
| Market Capitalization | 5.15 B | |||
| Z Score | 13.2 |
About Golden Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Golden Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Golden Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Golden Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Golden Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Golden Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Golden Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Golden Stock
| 0.76 | 1707 | Grape King Bio | PairCorr |
| 0.74 | 2330 | Taiwan Semiconductor | PairCorr |
| 0.72 | 2882 | Cathay Financial Holding | PairCorr |
| 0.7 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.67 | 2317 | Hon Hai Precision | PairCorr |
The ability to find closely correlated positions to Golden Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Golden Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Golden Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Golden Biotechnology to buy it.
The correlation of Golden Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Golden Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Golden Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Golden Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Golden Stock Analysis
When running Golden Biotechnology's price analysis, check to measure Golden Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Golden Biotechnology is operating at the current time. Most of Golden Biotechnology's value examination focuses on studying past and present price action to predict the probability of Golden Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Golden Biotechnology's price. Additionally, you may evaluate how the addition of Golden Biotechnology to your portfolios can decrease your overall portfolio volatility.